Opinion|Videos|December 14, 2023

Bladder Cancer: Treatment Options and Managing Adverse Effects

Author(s)Axel Merseburger, MD, PhD, M. Carmen Mir, MD, PhD, Shilpa Gupta, MD

Comprehensive insights on treatment considerations and managing immunotherapy-related adverse effects for patients with bladder cancer.

Episodes in this series

A panel of 4 experts on bladder cancer seated at a long table

EP. 1 Overview of Non–Muscle Invasive Bladder Cancer (NMIBC)

A panel of 4 experts on bladder cancer seated at a long table

EP. 2 Treatment Considerations and Role of Trimodal Therapy in Bladder Cancer

A panel of 4 experts on bladder cancer seated at a long table

EP. 3 Monitoring Patients With NMIBC

A panel of 4 experts on bladder cancer seated at a long table

EP. 4 Bladder Cancer: Treatment Options and Managing Adverse Effects

A panel of 4 experts on bladder cancer seated at a long table

EP. 5 Bladder Cancer: Highlights from ESMO 2023 and Ongoing Developments

A panel of 5 experts on bladder cancer

EP. 6 Enfortumab Vedotin and the Role of ADCs in Bladder Cancer

A panel of 5 experts on bladder cancer

EP. 7 Approach to Collaborative Care in Bladder Cancer

A panel of 4 experts on bladder cancer seated at a long table

EP. 8 Key Takeaways on Evolving Bladder Cancer Treatment Landscape

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Content

Alternative BCG strains may help address ongoing supply challenges in NMIBC

ByEugene B. Cone, MD

September 11th 2026

Phase 3 trial of padeliporfin VTP completes treatment in LG-UTUC

ByHannah Clarke

September 10th 2026

John Sfakianos, MD, discusses evolving management of recurrent LG-IR-NMIBC

ByJohn P. Sfakianos, MD

September 9th 2026

Dabogratinib shows early activity in FGFR3-altered LG-IR-NMIBC

ByHannah Clarke

September 9th 2026

The critical role of advocacy in urologic oncology

ByRuchika Talwar, MD,Lan Anh Galloway, MD

September 9th 2026

Latest CME

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Jeremie Calais, MD, PhD; Scott T. Tagawa, MD, MS, FACP, FASCO

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Trending on Urology Times

AI-generated profiles impersonate female urologists to market ED products online

The role of diet and lifestyle in prostate cancer care, with Lorelei A. Mucci, ScD, MPH

Doublet or triplet? Urologists weighs in on mCSPC options

John Sfakianos, MD, discusses evolving management of recurrent LG-IR-NMIBC

Alternative BCG strains may help address ongoing supply challenges in NMIBC